|
|
Article: Antigen Express tests melanoma vaccine with Fred Hutchinson clinician.
- Article from:
- Immunotherapy Weekly
- Article date:
- October 13, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 OCT 13 - (NewsRx.com & NewsRx.net) -- Generex Biotechnology Corp. (GNBT) announced that its wholly owned subsidiary, Antigen Express, has entered into a collaboration with Dr. Cassian Yee of the Fred Hutchinson Cancer Research Center, Seattle, Washington, to test the potency of a novel peptide vaccine for melanoma in stimulating cancer patients' immune cells.
Previous animal studies with this vaccine demonstrated dramatically more potent immune stimulation compared with prior vaccines investigated in the clinic.
"The extensive experience of Dr. Yee in clinical immunotherapy and focus on novel therapeutic strategies for melanoma perfectly ...